Mori H. Early detection and intervention in diabetic gastroparesis: Role of body surface gastric mapping. World J Gastroenterol 2024; 30(45): 4836-4838 [PMID: 39649543 DOI: 10.3748/wjg.v30.i45.4836]
Corresponding Author of This Article
Hideki Mori, MD, PhD, Senior Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 2-5-1 Higashigaoka, 35 Shinanomachi, Shinjuku-ku, Tokyo 1608582, Japan. koyamaru2002@yahoo.co.jp
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 7, 2024; 30(45): 4836-4838 Published online Dec 7, 2024. doi: 10.3748/wjg.v30.i45.4836
Early detection and intervention in diabetic gastroparesis: Role of body surface gastric mapping
Hideki Mori
Hideki Mori, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 1608582, Japan
Author contributions: Mori H wrote this paper.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hideki Mori, MD, PhD, Senior Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 2-5-1 Higashigaoka, 35 Shinanomachi, Shinjuku-ku, Tokyo 1608582, Japan. koyamaru2002@yahoo.co.jp
Received: June 15, 2024 Revised: October 5, 2024 Accepted: October 25, 2024 Published online: December 7, 2024 Processing time: 151 Days and 10.1 Hours
Abstract
Diabetic gastrointestinal neuropathy is a diabetes-related complication, associated with a complex interplay of hyperglycemic damage, autoimmune responses, oxidative stress, gastrointestinal hormones, and vascular insufficiency. Patients with diabetes should be monitored and therapeutic intervention introduced to prevent neuropathy due to diabetes prior to “the point of no return”. Determining gastric bioelectrical activity by body surface gastric mapping may be a promising option to monitor diabetic gastrointestinal neuropathy.
Core Tip: Gastroparesis is a frequent and sometimes life-threatening complication of diabetes, but no appropriate method has been established to evaluate its early onset. The author has high expectations for the future potential of body surface gastric mapping in this area. The article reviews the paper published in the World Journal of Gastroenterology in 2024 and discusses its findings and implications.
